Outlook on the Transfection Technologies Global Market to 2027 - Increasing Prevalence of Cancer and Various Chronic Lifestyle Diseases is Driving Growth
28 sept. 2022 04h28 HE
|
Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Transfection Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations
22 sept. 2022 08h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Viral Vector Manufacturing Market Tripling Its Size to Cross USD 1.5 Billion by 2028 | BlueWeave Consulting
20 sept. 2022 11h00 HE
|
BlueWeave Consulting and Research Pvt Ltd
New Delhi, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Global Viral Vector Manufacturing Market is surging at a robust growth rate during the forecast period, mainly due to the efficiency of viral vectors in...
Global Hemophilia Gene Therapy Market 2022: Featuring BioMarin, Spark, Pfizer, UniQure, Ultragenyx, Shire, Sangamo & Freeline
20 sept. 2022 05h23 HE
|
Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Hemophilia Gene Therapy Market, by Hemophilia Type, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added...
Worldwide Gene Therapy Industry to 2028 - Increasing Adoption of Gene Therapy for Oncological Disorders Will Provide Growth Opportunities
15 sept. 2022 07h23 HE
|
Research and Markets
Dublin, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The "Gene Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's...
Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
07 sept. 2022 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments
06 sept. 2022 16h05 HE
|
Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $36.7 Million -- -- Signed $41 Million in Net New Business Orders and Ended the Quarter with a Record High Backlog of $157 Million -- -- Facilities and...
Avid Bioservices Appoints Pramthesh (Prem) Patel, Ph.D., as Vice President, Process Development for Mammalian Cell Business
01 sept. 2022 08h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2023 After Market Close on September 6, 2022
30 août 2022 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
The Worldwide Viral Vectors and Plasmid DNA Manufacturing Industry is Expected to Reach $2.7 Billion by 2027
25 août 2022 04h58 HE
|
Research and Markets
Dublin, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Viral Vectors and Plasmid DNA Manufacturing Market (2022-2027) by Product Type, Application, Geography, Competitive Analysis and the Impact of...